Early ibuprofen not beneficial for preemies with patent ductus arteriosus

For extremely preterm infants, the risk for death or moderate or severe bronchopulmonary dysplasia is not significantly lower among those receiving early treatment for patent ductus arteriosus (PDA) with ibuprofen versus placebo, according to a study published in the Jan. 25 issue of the New England Journal of Medicine.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart